Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

NCT00050908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2013-07-29

No results posted yet for this study

Summary

This is a substudy of ACTG A5142. The purpose of this substudy is to evaluate blood vessel function in HIV-infected patients taking anti-HIV drugs.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Francesca J. Torriani, M.D. · University of California, San Diego

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00050908 on ClinicalTrials.gov